Gossamer Bio (GOSS) Share-based Compensation (IS) (2018 - 2024)
Gossamer Bio's Share-based Compensation (IS) was $5.81 million in Q1 2024, down 28.5% from $8.13 million a year earlier and down 3.7% from the prior quarter.
Powered by 
Analysis
Gossamer Bio (GOSS) Share-based Compensation (IS) (2018 - 2024) Analysis & Trends
On a trailing twelve-month basis, Gossamer Bio's Share-based Compensation (IS) was $26.2 million through Mar 31, 2024, down 34.0% year-over-year; for FY2023, it was $28.52 million, down 33.0% from FY2022.
- Share-based Compensation (IS) shows a five-year compound annual growth rate of -1.6% (FY2018 to FY2023).
- In earlier years, Share-based Compensation (IS) was $42.55 million in FY2022 (+32.9%), $32.01 million in FY2021 (-17.4%), $38.75 million in FY2020 (+86.1%) and $20.82 million in FY2019 (-32.7%).
- The Q1 2024 figure marks the lowest quarterly Share-based Compensation (IS) since Q3 2019.
- Compared with a year earlier, Share-based Compensation (IS) has declined for five straight quarters, with an average decline of 6.5% over the last eight quarters.
- The best year-over-year quarter for Share-based Compensation (IS) over five years was Q2 2019 (growth of 274.1%); the worst was Q3 2019 (a decline of 68.5%).
- Per Business Quant data, GOSS's Share-based Compensation (IS) in the three quarters before Q1 2024 was $6.03 million (Q4 2023), $6.16 million (Q3 2023) and $8.2 million (Q2 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Gossamer Bio | 46.08 Mn | -427.31 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 5.81 Mn |
| Dec 31, 2023 | 6.03 Mn |
| Sep 30, 2023 | 6.16 Mn |
| Jun 30, 2023 | 8.20 Mn |
| Mar 31, 2023 | 8.13 Mn |
| Dec 31, 2022 | 11.45 Mn |
| Sep 30, 2022 | 10.12 Mn |
| Jun 30, 2022 | 10.00 Mn |
| Mar 31, 2022 | 10.98 Mn |
| Dec 31, 2021 | 7.66 Mn |
| Sep 30, 2021 | 7.59 Mn |
| Jun 30, 2021 | 8.05 Mn |
| Mar 31, 2021 | 8.71 Mn |
| Dec 31, 2020 | 12.68 Mn |
| Sep 30, 2020 | 8.92 Mn |
| Jun 30, 2020 | 8.90 Mn |
| Mar 31, 2020 | 8.24 Mn |
| Dec 31, 2019 | 6.86 Mn |
| Sep 30, 2019 | 5.73 Mn |
| Jun 30, 2019 | 5.14 Mn |
API Access
Gossamer Bio Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=GOSS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "GOSS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=GOSS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();